Trump said so on Sunday (local time) at a press conference at the White House, shortly after the US Food and Drug Administration reported to the FDA that it was accelerating the use of convalescent plasma to treat certain corona patients. Earlier in the day, the Washington Post reported that Trump would make the use of plasma therapy public.
“This is an effective therapy,” the president told journalists about the treatment, which uses antibodies from the blood of donors who have already had the infection. “Today’s move will dramatically improve access to this treatment,” Trump said.
Minister Alex Azar (Public Health) said that more than 70,000 corona patients have now had plasma therapy and that initial research shows that the survival rate for people who received plasma was 35 percent higher.
Some experts believe the method can help fight the virus, but it is by no means a major breakthrough. Trump himself spoke of a “historic breakthrough” in the treatment of the lung virus that “will save countless lives”.
Research is also being carried out in the Netherlands with the support of the Sanquin blood bank, which buys antibodies against corona for the development of a drug against Covid-19.
“Our” vaccine is gaining momentum?
The Financial Times reported Sunday that the Trump administration is considering accelerating an experimental vaccine from British-Swedish pharmaceutical company AstraZeneca and the University of Oxford so that it can be used in emergencies ahead of the November 3 election in the US. . The Netherlands, among others, have already ordered millions of doses of the promising vaccine.